Dimethoxybromoamphetamine (DOB), also known as Brolamfetamine and Bromo-DMA, is a psychedelic drug and substituted amphetamine of the phenethylamine (a neurotransmitter abundant in chocolate) class of compounds (e.g. MDMA). DOB was first synthesized by American pharmacologist Alexander Shulgin in 1967. In his book ‘PiHKAL: A Chemical Love Story,’ Shulgin lists the dosage range as 1 to 3 mg, which is generally taken orally. According to Shulgin, the effects of DOB last 18 to 30 hours. Onset of the drug is also long, sometimes taking up to three hours. The toxicity of DOB is not fully known, although high doses may cause serious vasoconstriction of the extremities.
DOB has been sold on blotter paper (and presumably represented as LSD). Misrepresentation as LSD could be potentially dangerous, as DOB does not have the known safety profile of LSD: unlike LSD, DOB can have physically harmful (if not fatal) effects in overdose. Upon tasting the chemical, if one notices a highly bitter or ‘chemically’ taste, this should serve as a warning sign that the drug is not LSD, but likely a psychedelic amphetamine (DOB, DOC, DOI, or Bromo-DragonFLY). However, blotter paper may have a taste regardless of the chemical on it, due to ink or solvent used.